The GuruFocus All-In-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “June 2017” and All Insider Sales to “$5,000,000+.”
According to the above filters, the following are trades from company insiders this week.
International Flavors & Fragrances Inc. (IFF) 10% owner Winder Investment Pte. Ltd. bought 40,000 shares for $136.63 per share on June 21. Since then, the stock price has declined to $135.13.
It is engaged in manufacturing and supplying of flavors and fragrances for the food, beverage, personal care and household products industries either in the form of compounds or individual ingredients.
The company has an institutional ownership of 69.73% and insider ownership of 1.79%.
Over the last 12 months, the stock price has risen by 7%, and the price is 5.26% below its 52-week high and 20.25% above its 52-week low.
Medley Capital Corp. BDCÂ (MCC) CEO Brook Taube and Director Seth Taube bought 823,272 shares for $6.35 per share on June 20. Since then, the stock price has declined to $6.24.
It is a close-ended management investment company. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies.
The company has an institutional ownership of 33.09% and insider ownership of 0.53%.
Over the last 12 months, the stock price has dropped by 6% and is now trading with a price-earnings (P/E) ratio of 62.40. The price is 22.58% below its 52-week high and 5.95% is above its 52-week low.
Revlon Inc. Class AÂ (REV) Director and 10% owner Ronald O. Perelman bought 255,681 shares for $22.94 per share on June 20. Since then, the stock price has risen to $23.30.
It is a cosmetics company. It manufactures, markets and sells cosmetics, women's hair color, beauty tools, fragrances, skin care, anti-perspirants/deodorants and personal care products.
The company has an institutional ownership of 15.55% and insider ownership of 15.04%.
Over the last 12 months, the stock price has risen by 30%, and the price is 38.22% below its 52-week high and 29.20% above its 52-week low.
Most important insider sales
Box Inc. (BOX) Director Rory O'Driscoll sold 332,992 shares for $19.04 per share on June 22. Since then, the stock price has declined to $18.95.
It provides a cloud content management platform that enables organizations of all sizes to securely manage cloud content while allowing easy, secure access and sharing of this content from anywhere on any device.
The company has an institutional ownership of 28.46% and insider ownership of 0.44%.
Over the last 12 months, the stock price has risen by 66% and is now trading with a price-book (P/B) ratio of 42.71. The price is 9.37% below its 52-week high and 92.19% above its 52-week low.
Adamas Pharmaceuticals Inc. (ADMS) 10% owner Great Point Partners LLC sold 380,000 shares for $17.08 per share on June 21. Since then, the stock price has declined to $16.82.
It is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company is developing its wholly owned product candidate, ADS-5102.
The company has an institutional ownership of 65.29% and insider ownership of 1.68%.
Over the last 12 months, the stock price has risen by 5% and is now trading with a P/B ratio of 3.20. The price is 12.41% below its 52-week high and 41.16% above its 52-week low.
HealthEquity Inc. (HQY) director Frank Medici and 10% owner Berkley Capital LLC sold 308,530 shares for $51.94 per share on June 21. Since then, the stock price has declined to $51.05.
It is a technology-enabled services platform that empowers consumers to make health care saving and spending decisions. Its products and services include health care saving and spending platform, health savings accounts and health care incentives.
The company has an institutional ownership of 87.40% and insider ownership of 1.18%.
Over the last 12 months, the stock price has risen by 76% and is now trading with a P/B ratio of 10.59. The price is 6.39% below its 52-week high and 89.61% above its 52-week low.
Disclosure: I do not own any shares of any stocks mentioned in this article.
